Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-25,700
Closed -$45K – 12686
2024
Q3
$45K Sell
25,700
-22,400
-47% -$44K ﹤0.01% 11419
2024
Q2
$104K Sell
48,100
-16,000
-25% -$42.9K ﹤0.01% 11006
2024
Q1
$191K Buy
64,100
+26,300
+70% +$71.1K ﹤0.01% 10638
2023
Q4
$106K Buy
37,800
+7,600
+25% +$20K ﹤0.01% 11278
2023
Q3
$76.7K Buy
+30,200
New +$57.3K ﹤0.01% 11092
2021
Q3
– Sell
-10,300
Closed -$73K – 13138
2021
Q2
$73K Sell
10,300
-1,200
-10% -$9.12K ﹤0.01% 12204
2021
Q1
$78K Buy
+11,500
New +$66.2K ﹤0.01% 11938

Other funds holding IRIX

Jeff Yass's IRIX Position: Q3 2026 in Review

Jeff Yass reduced its IRIDEX (IRIX) stake by 36% in Q3 2026, selling an estimated $8.13K and leaving 17,545 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #13215.

Jeff Yass first reported a position in IRIX in Q4 2016 and has held it in 19 quarters since. The position peaked at $298K in Q4 2023. 26 funds tracked by Wall St. Rank hold IRIX as of Q3 2026.

  • Jeff Yass held 17,545 shares of IRIDEX worth $11.1K as of Q3 2026.
  • Jeff Yass sold 9,914 IRIDEX shares in Q3 2026, an estimated $8.13K.
  • IRIDEX made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13215 holding.
  • Jeff Yass first reported a position in IRIDEX in Q4 2016 and has held it in 19 quarters since.
  • Jeff Yass's IRIDEX position peaked at $298K in Q4 2023.
  • 26 funds tracked by Wall St. Rank held IRIDEX as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.